Gregory Sgammato

Gregory Sgammato currently serves as Senior Vice President at Amneal Pharmaceuticals since July 2020, following a role as Vice President of Corporate Development and M&A. Prior experience includes serving as a Portfolio Manager at Tarsadia Investments from August 2017 to July 2020, focusing on healthcare and crossover investments. Gregory's background in investment banking includes positions as Vice President and M&A Analyst in the Industrials Group at Lazard from June 2013 to July 2015, and earlier as an Investment Banking Summer Analyst at Stifel Nicolaus Weisel. Prior internships include roles at BNY Mellon and Middleton Gardiner Group, as well as a Research Assistant position at Johns Hopkins University. Gregory holds a Master of Arts in International Economics from Johns Hopkins School of Advanced International Studies and a Bachelor of Science in Economics and International Studies from The Johns Hopkins University.